Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Financial Other
confidence 85%
filed 2026-07-22
Item 8.01
The filing discloses the Company's Net Asset Value (NAV) per share as of June 30, 2026, broken down by share class, along with detailed component analysis and month-over-month comparison to May 31, 2026. This is a routine financial disclosure for a closed-end fund or similar investment vehicle, material to investors in assessing the value of their holdings, but does not fit the specific categories of earnings_release, debt_issuance, dividend_distribution, or other named financial event types. It is clearly financial in nature and warrants classification as financial_other.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-22
Item 8.01
Princeton Bancorp's Board declared a quarterly cash dividend of $0.35 per share, payable August 28, 2026, to shareholders of record as of August 5, 2026. This is a routine but material dividend declaration that directly returns capital to shareholders and signals the company's financial health and capital position to investors.
View raw filing on EDGAR →
8-K
Operational Other
confidence 73%
filed 2026-07-22
Item 1.01
QuantumScape amended its collaboration agreement with PowerCo (Volkswagen Group subsidiary) to restructure the joint development program for QSE-5 battery technology, replacing the prior cost-reimbursement structure with milestone-based payments totaling $75.4 million over two years focused on automotive cell development and commercialization.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-22
Item 5.02
Douglas Kling, the Company's Chief Operating Officer, notified the company on July 16, 2026 of his resignation effective August 14, 2026 to join another biotech company as CEO. This is a clear executive departure of a named officer. While the filing mentions anticipated separation and advisor agreements, the principal disclosed action is Kling's departure from his COO role, making exec_departure the most salient classification.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-22
Item 1.01
Tempest entered into a material strategic collaboration agreement with Senlang Biotechnology for product development and an investigator-initiated trial of TPST-4003 in China, including development fees, data rights, and an exclusive option for Senlang to negotiate a license for China rights. The agreement represents a significant operational and strategic milestone advancing the company's lead product candidate into first-in-human studies.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-22
EX-99.1
Baidu announced its voluntary conversion from secondary to dual-primary listing status on the Hong Kong Stock Exchange, with shareholder resolutions proposed for an issuance mandate, share repurchase mandate, adoption of a 2026 Share Incentive Plan, and amendments to the memorandum and articles of association to comply with Hong Kong Listing Rules.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-07-22
EX-99.1
Sunrise announced the successful pricing of a new EUR 500 million Senior Secured Notes due 2033 on 20 July 2026, with closing expected 3 August 2026. The proceeds will refinance existing debt due 2029 and extend the debt maturity profile. This is a material debt issuance creating a new direct financial obligation, distinct from a refinancing of existing obligations, and materially affects the registrant's capital structure and leverage profile.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-22
Item 2.01
Northfield Bancorp completed a merger with Columbia Financial, with Columbia Financial as the surviving corporation. Northfield shareholders received $14.25 cash or 1.425 Columbia Financial shares per share, and Northfield's board members and CEO were appointed to roles at Columbia.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-22
Item 3.01
Northfield Common Stock was delisted from NASDAQ effective July 20, 2026, following completion of the merger with Columbia Financial. Columbia Financial intends to file Form 15 to deregister the stock and suspend reporting obligations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-22
Item 2.02
First American Financial Corporation issued a press release on July 22, 2026, announcing its financial results for the quarter ended June 30, 2026. The disclosure includes key metrics such as earnings per diluted share of $2.12 ($2.08 adjusted), total revenue of $2.1 billion (up 15% year-over-year), net income of $218.5 million, and segment-level performance data. This is a standard quarterly earnings release furnished under Item 2.02 of Form 8-K, with the full press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-22
Item 5.02
Jeffrey Hanson appointed as permanent CEO (effective July 21, 2026) after serving as Interim CEO since February 2026; Gabe Willhite promoted to President and COO; and Scott Estes appointed Lead Independent Director. Danny Prosky retired from his CEO role as part of this leadership succession.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-22
Item 2.02
QuantumScape announced its Q2 2026 business and financial results on July 22, 2026, with a shareholder letter and press release furnished as Exhibits 99.1 and 99.2. The filing discloses quarterly operating expenses ($106.1M), net loss ($98.2M), adjusted EBITDA loss ($64.2M), capital expenditures ($4.6M), customer billings ($10.8M), and liquidity position ($859.0M), along with full-year 2026 guidance. This is a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-22
Item 2.02
Third Coast Bancshares issued a press release on July 22, 2026, announcing its financial results for the quarter ended June 30, 2026, disclosing net income of $22.0 million, record diluted EPS of $1.08, and a 22.1% increase in net interest income year-over-year. The company also announced an investor call and webcast to discuss the results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-22
Item 2.02
Richardson Electronics issued a press release on July 22, 2026, announcing financial results for the fourth quarter and fiscal year ended May 30, 2026. The disclosure includes detailed quarterly and annual net sales ($66.2M and $228.6M respectively), net income ($3.7M and $6.4M), and earnings per share ($0.25 and $0.44 diluted), along with key operational metrics such as backlog growth and margin analysis. The company also declared a quarterly cash dividend. This is a standard earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-22
Item 2.02
Equity Residential issued a press release on July 22, 2026 announcing its results of operations and financial condition for the quarter and six months ended June 30, 2026, including key metrics such as EPS, FFO per share, and Normalized FFO per share. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures. The company also raised full-year operating guidance for same store revenues and NOI.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-22
Item 8.01
The Board of Directors approved and declared a quarterly dividend of 18 cents per common share, payable to shareholders of record on August 4, 2026 (per Item 8.01) or August 14, 2026 (per the press release). This represents a regular quarterly dividend distribution of approximately $3.7 million, consistent with the prior quarter. The disclosure is a straightforward dividend declaration, which is material to investors as it affects shareholder returns and capital allocation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-22
Item 2.02
Lake Shore Bancorp issued a press release on July 22, 2026 disclosing quarterly and year-to-date financial results for the period ended June 30, 2026. The disclosure includes net income of $2.2 million ($0.29 per diluted share) for Q2 2026 versus $1.9 million ($0.25 per share) in Q2 2025, along with comprehensive financial metrics including net interest income, efficiency ratios, return on assets, and credit quality measures. This is a standard earnings release under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-22
Item 2.02
Community Health Systems disclosed Q2 2026 financial results with net operating revenues of $2.825 billion, net income of $70 million ($0.51 per diluted share), and Adjusted EBITDA of $330 million, along with updated 2026 annual earnings guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-22
Item 2.02
Getty Realty Corp. issued a press release on July 22, 2026 announcing its financial and operating results for the quarter ended June 30, 2026, disclosing net earnings of $0.36 per share, FFO of $0.59 per share, AFFO of $0.62 per share, and increasing 2026 full-year earnings guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-22
Item 2.02
Kaiser Aluminum issued a press release on July 22, 2026 reporting preliminary, unaudited financial results for Q2 2026 ended June 30, 2026. The disclosure includes record net sales of $1.3 billion, net income of $97 million ($5.72 per diluted share), and adjusted EBITDA of $166 million with a 38.1% margin. The company also raised its full-year 2026 outlook for conversion revenue and adjusted EBITDA growth. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-22
Item 5.07
This Item 5.07 disclosure reports the final voting results from Genesco Inc.'s Annual Meeting of Shareholders held on July 21, 2026, including election of nine directors, advisory approval of named executive officer compensation, approval of the Fourth Amended and Restated 2020 Equity Incentive Plan, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents tabulated vote counts for each matter, which is the core purpose of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-22
Item 5.07
This Item 5.07 discloses the results of a special stockholder meeting held on July 22, 2026, where TMHC shareholders voted on three proposals: (1) adoption of a Merger Agreement with Berkshire Hathaway Inc. (75,830,360 votes for, 2,333,091 against), (2) advisory approval of executive compensation in connection with the merger (70,009,828 for, 8,095,053 against), and (3) an adjournment proposal (not submitted). The merger proposal received overwhelming shareholder approval, making this a material shareholder vote result that directly enables the M&A transaction to proceed.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-22
EX-99.1
This exhibit is a press release announcing MindWalk's fiscal 2026 financial results for the year ended April 30, 2026. It discloses full-year revenue of $15.6 million (up 46%), gross margin expansion to 59%, and net loss narrowed by more than half to $13.9 million. The document includes consolidated financial statements (income statement, balance sheet, cash flows) and detailed quarterly and annual results, which are characteristic of an earnings release. This is material to investors as it shows significant revenue growth, margin improvement, and reduced losses during a strategic pivot to Bio-Native AI infrastructure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-22
Item 3.02
The Company sold 1,029,197 Class I common shares for $24.9 million in aggregate consideration to accredited investors pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 90%
filed 2026-07-22
Item 8.01
The Company declared a monthly distribution of $0.1834 per share on Class I common shares as of June 30, 2026, and reported a NAV per share of $24.1828 for Class I, along with portfolio composition and valuation metrics.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-07-22
EX-99.1
Nomad Foods announces the pricing of €800.0 million aggregate principal amount of 5¼% Senior Secured Notes due 2033, with proceeds intended to refinance existing €800.0 million Senior Secured Notes due 2028. This is a material debt issuance creating a new direct financial obligation, extending the company's next material long-term debt maturity to 2032. The announcement also includes an expected €105.0 million upsize to the revolving credit facility, further evidencing material capital structure activity.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-07-22
EX-99.1
C3is Inc. effected a 1-for-7 reverse stock split on April 26, 2026, reducing outstanding shares from 3.8 million to approximately 541,082 shares. While reverse splits are capital structure events, they are most closely aligned with `dividend_distribution` in the taxonomy as they represent a return-of-capital transaction affecting all shareholders uniformly. The disclosure includes retroactive adjustment of share counts and EPS figures, and cash payments to shareholders for fractional shares, which is material to investors' understanding of the company's capitalization and historical per-share metrics.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-07-22
EX-99.1
Obsidian Energy announces the closing of a $75 million add-on offering of senior unsecured notes due December 3, 2030, issued at 102.75% of face value with gross proceeds of $77.9 million. This is a material creation of new direct financial obligations under existing debt instruments, increasing the aggregate principal amount of the Notes from $175.0 million to $250.0 million. The disclosure explicitly states the Notes are "direct senior unsecured obligations of Obsidian Energy, ranking equal with all other present and future senior unsecured indebtedness," which is the hallmark of a debt issuance event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-22
Item 2.01
Public Storage completed its acquisition of National Storage Affiliates Trust (NSA), adding over 1,000 properties and 550,000 units to create a combined portfolio of 4,500+ properties. The transaction involved an exchange ratio of 0.14 Public Storage common shares per NSA share, issuance of approximately 11.2 million Public Storage common shares and preferred shares, and formation of a joint venture with $3.2 billion in real estate assets and $2.2 billion in financing. The acquisition is expected to be accretive to FFO per share with $110–$130 million in run-rate synergies.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-22
Item 2.03
As part of the NSA acquisition closing, the joint venture obtained approximately $2 billion in secured mortgage financing from Goldman Sachs and Wells Fargo, plus $237 million in mezzanine financing from Public Storage, creating material new direct financial obligations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-22
Item 8.01
Dyne Therapeutics announced the pricing of an upsized $375 million public offering of 18.3 million shares of common stock at $20.50 per share, with underwriters holding a 30-day option to purchase an additional 2.745 million shares.
View raw filing on EDGAR →
8-K
Cybersecurity Incident
confidence 92%
filed 2026-07-22
Item 8.01
The disclosure describes a material cybersecurity incident involving unauthorized access to an employee's Company-issued computer via social engineering, with exfiltration of files. Although the Company states it does not believe the incident has had a material impact on operations, the fact that it was disclosed on Form 8-K Item 8.01 and involved a threat actor gaining access and exfiltrating data triggers the cybersecurity_incident classification. The incident meets the materiality threshold for disclosure under Item 1.05 (cybersecurity incidents required since 2023), and a reasonable investor would consider unauthorized access and data exfiltration to be material information affecting risk assessment.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-22
Item 8.01
Netflix completed a registered public offering of $1 billion in 5.250% senior unsecured notes due 2036 on July 22, 2026. This is a material creation of a direct financial obligation through debt issuance. The company intends to use proceeds for repayment of existing notes and general corporate purposes, which is typical debt refinancing activity disclosed under Item 8.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-22
Item 2.01
Scilex completed the disposition of previously acquired preferred shares to Vivasor for approximately $12 million, payable in tranches through June 2027. The transaction involves a related-party element given the CEO's role at Vivasor and represents a material capital transaction affecting the registrant's asset base and strategic positioning.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-22
EX-99.1
Radiopharm Theranostics announced positive Phase 1 clinical trial results for RAD204, including a RECIST-confirmed durable partial response in an advanced solid tumor patient and favorable safety data, representing material progress on the company's lead therapeutic program.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-22
EX-99.2
Radiopharm Theranostics announced positive Phase 2b clinical trial results for RAD101, a diagnostic imaging radiopharmaceutical, achieving the primary endpoint of 93% concordance with MRI and 86% sensitivity, with advancement to Phase 3 pivotal trials planned for Q4 2026.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-22
EX-99.3
This is a press release announcing unaudited financial results for the six months ended April 30, 2026, disclosing total revenue of $137.5 million (a 38.3% increase year-over-year), ocean freight revenue details, voyage metrics, and strategic expansion into lithium resources transportation. The disclosure of interim financial results with material revenue growth and operational metrics is a classic earnings release event.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-22
Item 1.01
SunPower entered into settlement agreements on July 17, 2026 to settle OTC Equity Prepaid Forward Transactions by issuing an aggregate of 17,900,462 shares of common stock (Initial FPA Shares), with potential for additional shares issuable based on trading price during a valuation period. The shares were issued unregistered under Section 4(a)(2) exemption with registration rights granted to recipients, representing a material dilutive equity issuance and significant capital structure change.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-22
Item 1.01
Apex Treasury Corp (a SPAC) entered into a definitive business combination agreement with TECfusions, Inc., valuing TECfusions at $4.0 billion in an all-stock transaction. The merger will result in TECfusions becoming a publicly traded company on Nasdaq, representing a material change of control.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-22
Item 3.02
Apex Treasury Corp issued $35 million in unregistered PIPE shares at $10.00 per share to a PIPE investor in connection with the TECfusions business combination, representing a dilutive equity issuance under Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-22
EX-99.1
This press release announces NeuroSense's decision to proceed with filing a New Drug Submission (NDS) to Health Canada for PrimeC in ALS, following a constructive Pre-NDS meeting. The disclosure highlights achievement of the primary TDP-43 biomarker endpoint (p=0.0421) and a meaningful 14.9-month median survival benefit (HR 0.35, p=0.0037) from the Phase 2b PARADIGM study. This is a material regulatory milestone in the clinical development pathway for the company's lead product candidate, representing significant progress toward commercialization. While not a discrete event type like M&A or exec change, it is a material operational/strategic advancement in product development that would affect a reasonable investor's assessment of the company's prospects.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-22
Item 1.01
CID HoldCo entered into a Securities Purchase Agreement on July 22, 2026, to issue convertible preferred stock (Series AA and Series B) for $6.0 million aggregate purchase price. The convertible preferred stock is convertible into common shares, and the transaction requires stockholder approval for the issuance of the Conversion Shares, with restricted account mechanisms and board designation rights typical of PIPE-like transactions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-22
Item 5.02
Joseph Risico was appointed as a director to fill an existing Class I vacancy, and Ryan Daiss was appointed as President with detailed employment terms including base salary, performance bonuses, equity awards, and severance provisions.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-22
EX-99.2
PS International Group Ltd. is soliciting shareholder votes on three governance proposals at an Extraordinary General Meeting scheduled for August 18, 2026: adoption of amended memorandum and articles of association, change of authorized share capital from 62.5 million to 10 billion shares, and authorization of registrar filings. The substantial increase in authorized share capital and amendment of foundational corporate documents are material to shareholders' assessment of the company's capital structure and governance framework.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-22
Item 7.01
Evolution Metals announced receipt of its first shipment of neodymium-praseodymium (NdPr) metal from Senri Trading Co., Ltd., a five-metric-ton delivery that operationalizes the company's non-China feedstock supply chain for defense-compliant rare earth magnet production. This is a material operational milestone directly aligned with the July 20, 2026 White House Executive Order on critical defense supply chains and the January 1, 2027 DFARS deadline, positioning the company as potentially the only commercial-scale producer of DFARS-compliant magnets. While this is a significant business development and supply chain achievement, it does not fit neatly into the specific event categories (e.g., it is not an M&A transaction, debt issuance, or workforce action), making operational_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-22
Item 3.01
Purple Innovation received a Nasdaq Panel decision on July 20, 2026 granting continued listing subject to strict conditions: the company must demonstrate a closing bid price of at least $1.00 per share for a minimum of ten consecutive trading days by July 31, 2026. The filing explicitly discloses delisting risk, noting "there can be no assurance that the Company will regain compliance" and that failure to do so would result in delisting from Nasdaq. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-22
EX-99.1
This press release announces a strategic cooperation agreement between Ping An Biomedical and Yuan Sheng Mei Yan targeting RMB 500 million in cumulative sales over three years. The agreement establishes a channel development partnership combining Ping An's biotechnology products with Yuan Sheng Mei Yan's health services and distribution capabilities. While this is a material commercial partnership that could significantly impact revenue and market expansion, it does not fit the specific event categories (M&A, debt, equity issuance, etc.) and is best classified as an operational/strategic business event.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-22
EX-99.1
This press release announces a non-binding term sheet for a PIPE (private investment in public equity) financing in which the Buyer intends to subscribe for securities with consideration of approximately 3,500 Bitcoin. The transaction also contemplates a control transition whereby the Buyer would designate a majority of the board of directors. This is a dilutive equity issuance to a private investor that would materially affect shareholder ownership and control, making it a material disclosure under the dilutive_issuance category.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-22
The 6-K discloses a private placement of 23,000,000 new ordinary shares at KRW 1,600 per share (total KRW 36.8 billion / HKD 194.7 million) to three named subscribers, subject to shareholder approval at an Extraordinary General Meeting on August 6, 2026. This is a material dilutive equity issuance that would significantly affect existing shareholders' ownership percentages and voting power.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-22
The disclosure reports issuance of 2.5 million Class A and 200,000 Class B ordinary shares to More Healthy Holdings Limited (the holding vehicle of Mr. Weiguang Yang, the CEO and Chairman) on July 21, 2026, "in consideration and acknowledgement of Mr. Weiguang Yang's services rendered to the Company." This is an equity grant to a named executive officer approved by the Audit Committee and Compensation Committee, fitting the definition of executive compensation. The transaction is material because it results in Mr. Yang holding 99.45% of aggregate voting power and represents a substantial equity award to the controlling executive.
View raw filing on EDGAR →